Advisory Services Network, LLC Kodiak Sciences Inc. Transaction History

Advisory Services Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$6.52 - $8.05 $163 - $201	25 New	25 $0
Q3 2021 Nov 05, 2021	SELL	$81.97 - $106.94 $116,643 - $152,175	-1,423 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$77.2 - $126.54 $109,855 - $180,066	1,423 New	1,423 $132,000
Q1 2021 May 24, 2021	SELL	$110.45 - $164.47 $24,851 - $37,005	-225 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$45.05 - $59.27 $10,136 - $13,335	225 New	225 $13,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.